What are the pathways for high-risk medical devices? How does the Reliance Route work? CMEF Southeast Asia Open Class: Thailand Session
Views:94
Time:2026-11-05 14:30:00


Thailand is a large population country in Southeast Asia with strong market demand for medical devices. The Thai FDA (TFDA) classifies devices into 4 risk classes (Class 1–4). The maximum review period for Class 4 high-risk devices can reach 300 working days. Besides full review and abridged review, there is a unique Reliance fast-track route that accepts approvals from Singapore HSA. This open class at Beijing CMEF breaks down the full registration workflow for high-risk medical devices in Thailand and sorts out key pitfalls to avoid.



一、Risk Classification: 4 Tiers (Class A–D)



Thailand’s medical device regulator is the Thai FDA (TFDA), governed by the Medical Device Act B.E. 2551 (2008) as amended in 2019.

Note: If the primary mechanism of action of a product is pharmacological, immunological or metabolic, it will be classified as a pharmaceutical product and does not fall under medical device regulations.


ClassRisk LevelRegulatory RouteKey Notes
Class 1Low RiskListingDocument checklist only; no expert review
Class 2Low-to-Medium RiskNotificationExpert review required
Class 3Medium-to-High RiskNotificationExpert review with deeper scrutiny than Class 2
Class 4High RiskLicenseMandatory expert review; maximum review period of 300 working days

This classification framework applies uniformly to both IVD and non-IVD devices. Class 2 and Class 3 both follow the Notification route but differ in review depth.
二、Comparison of Three Registration Pathways



(一)Full Review Route
The only option without overseas reference approvals. It requires the most complete documentation and undergoes the strictest assessment.

(二)Abridged Review Route
Eligibility:Hold a valid approval from one of the following: EU NB, Canada HC, Japan MHLW, Australia TGA, US FDA, WHO PQ (IVD only). The device must have been on the market for at least 1 year with no serious adverse events. Compared with the full route, it saves 2–3 months; some technical verification documents may be waived.

(三)Reliance Scheme

Policy updated in 2022: Covers all Singapore HSA Class B/C/D devices.

Mechanism: Thailand unilaterally recognises Singapore HSA registration outcomes, waives expert review, shortening the timeline by 1–3 months.

Important reminder: Singapore does NOT recognise Thai approvals under this scheme; Singapore registration remains an independent review.

Mandatory conditions: The CSDT dossier submitted in Thailand must be identical to the Singapore registration package, accompanied by a signed consent letter from the Singapore registration holder. Home-use devices still require full Thai-language labelling and IFU.

三、Document Differences: Full vs Abridged Route



Both routes adopt the ASEAN CSDT framework. Core differences are listed below:
  • Mandatory documents for both routes: Labelling, Summary, ISO 13485 certificate, Declaration of Conformity (DoC)
  • Full Route: Full set of verification & validation records, risk analysis documentation
  • Abridged Route: Verification & validation records can be exempted
  • Additional documents for Abridged Route: Manufacturer indication statement, market history statement, no-adverse-event statement, overseas approval certificate

ISO 13485 certificate is mandatory; applications will be rejected outright if missing.

四、Scenarios Triggering Mandatory Expert Review



In addition to the inherent requirements for Class 2–4, expert review is automatically triggered if any of the following apply:
  • New technologies not yet adopted in Thailand (AI diagnostic / AI therapeutic devices)
  • Change of intended setting (e.g. hospital use changed to home use)
  • Aesthetic medicine / autologous treatment products (e.g. thread lifting, facial contouring devices)
  • History of serious adverse events
  • Devices listed under official control announcements (blood bags, HIV test kits, etc.)
五、Labelling & IFU Language Requirements



  • Home-use devices: Full Thai-language labelling and instructions for use (IFU) are mandatory. English-only or partial translation summaries are not acceptable.
  • Professional hospital-use devices: English is acceptable per TFDA FAQs. Absolute promotional claims must be avoided.
  • Full internal, external and shipping packaging drawings are required. Labels must bear the notification / licence reference number.
  • Full details of the local Thai Authorised Representative (AR) must be printed on the label.
六、Review Timelines & Certificate Maintenance



Risk ClassReference Review Timeline
Class 130–60 working days, Listing
Class 2 / 3~150 working days; Abridged route is 2–3 months faster
Class 4~200 working days, capped at 300 working days

  • Certificate validity: 5 years
  • AR annual fee: Due date is 1 day prior to the original grant date; payment must be made on time.
  • Timelines are working days, excluding Thai public holidays. Build sufficient buffer into project schedules.
  • For approved changes, the change category must be assessed in advance. Some variations require TFDA approval before implementation.
七、Common Deficiencies & Real Cases



  • Incorrect classification or pathway selection, missing classification rationale
  • Missing local AR authorisation letter or company licence
  • Incomplete Thai IFU for home-use products
  • Mismatch of product name, model and indications across CSDT, application form and labels
  • Outdated test standards, requiring gap analysis between old and new editions
  • CVs and conflict-of-interest statements for clinical / biological evaluators (TFDA places strong emphasis on assessor qualification)
  • Missing justification for the selection of representative models and worst-case assumptions
八、Closing Remarks



Supported by the Skynet online system and reference pathways, TFDA offers flexible registration routes for medical device exporters. Local authorised representative appointment, post-market surveillance and document updates are critical for sustained compliance. Early classification determination and alignment of technical files help shorten the approval cycle. Companies can leverage Thailand as a hub to expand into the ASEAN market and steadily build their footprint across Southeast Asia.For further enquiries, please contact Wiselink.

Contact Us
Fill Form
Whether you need more information or wish to cooperate with us, we will guide you through every step of the regulatory process. Subscribe to our newsletter for the latest global regulatory updates.